CANCELLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 326
EU - Europa 310
AS - Asia 101
AF - Africa 5
OC - Oceania 1
SA - Sud America 1
Totale 744
Nazione #
US - Stati Uniti d'America 321
IT - Italia 208
SG - Singapore 51
SE - Svezia 34
IN - India 16
ID - Indonesia 15
CN - Cina 12
DE - Germania 10
FI - Finlandia 10
IE - Irlanda 8
BG - Bulgaria 6
CA - Canada 5
RO - Romania 5
HK - Hong Kong 4
RS - Serbia 4
TG - Togo 4
GR - Grecia 3
NL - Olanda 3
UA - Ucraina 3
BE - Belgio 2
CH - Svizzera 2
GB - Regno Unito 2
LU - Lussemburgo 2
PT - Portogallo 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
FR - Francia 1
HR - Croazia 1
MY - Malesia 1
PH - Filippine 1
PL - Polonia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 744
Città #
Rome 73
Fairfield 42
Singapore 42
Chandler 37
Ashburn 23
Jakarta 15
Houston 13
Cambridge 12
Seattle 12
Wilmington 12
Woodbridge 11
New York 10
Princeton 10
San Paolo di Civitate 10
Pesaro 9
Dearborn 8
Helsinki 8
Lawrence 7
Milan 7
San Diego 7
Santa Clara 7
Dublin 6
Sofia 6
Ann Arbor 5
Dallas 5
Florence 5
Boston 4
Hangzhou 4
Hong Kong 4
Lomé 4
Millbury 4
Naples 4
San Mateo 4
Belgrade 3
Biancavilla 3
Boardman 3
Chennai 3
Chicago 3
Fiuggi 3
Lucca 3
Toronto 3
Verona 3
Amsterdam 2
Andover 2
Aosta 2
Athens 2
Bari 2
Beijing 2
Berlin 2
Bern 2
Bremen 2
Catania 2
Civitavecchia 2
Des Moines 2
Fremont 2
Hyderabad 2
Lappeenranta 2
Leuven 2
Macerata 2
Nanchang 2
Norwalk 2
Piacenza 2
Plano 2
Porto 2
Rodano 2
Albano Laziale 1
Brno 1
Bühl 1
Changsha 1
Chieti 1
Cologne 1
Dearborn Heights 1
Gdynia 1
Gozzano 1
Groningen 1
Guangzhou 1
Ischia di Castro 1
Islington 1
Kilburn 1
Kragujevac 1
Leander 1
Los Angeles 1
Marseille 1
Melbourne 1
Montréal 1
Muizenberg 1
Novara 1
Ottawa 1
Phoenix 1
Piraeus 1
Redwood City 1
Romola 1
Ronciglione 1
San Bonifacio 1
Santa Maria 1
Sesto Fiorentino 1
Tallinn 1
Tashkent 1
Teramo 1
Timisoara 1
Totale 538
Nome #
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value 92
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection 76
Role of double-carbapenem regimen in the treatment of infections due to carbapenemase producing carbapenem-resistant enterobacteriaceae: a single-center, observational study 72
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature 65
Curb-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with sars-cov-2 pneumonia 60
Real-life experience in the use of ceftobiprole for the treatment of nosocomial pneumonia: a case series 48
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies. Results from the HM-COV 2.0 study 46
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature 46
Low-grade endotoxemia and thrombosis in COVID-19 41
Effect of n-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant klebsiella pneumoniae and acinetobacter baumannii. A retrospective case-control study 37
Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19 35
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations 32
Challenges in the Clinical Management of {SARS}-{CoV}2-Infected Patients with Haematological Malignancies 26
Role of serum e-selectin as a biomarker of infection severity in coronavirus disease 2019 24
null 24
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study 21
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections. A single-center preliminary experience 14
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems. A multicentric propensity score-weighted observational cohort study 12
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study 11
null 10
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study (Infection, (2022), 50, 5, (1373-1382), 10.1007/s15010-022-01869-w) 8
null 7
null 5
null 4
Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study 4
Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case–control study 2
Totale 822
Categoria #
all - tutte 3.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 0 0 0 7 7 8 4 4 3 2 7
2020/202177 2 2 0 2 4 10 0 0 29 10 6 12
2021/2022129 8 10 6 11 9 5 3 6 16 1 32 22
2022/2023185 22 31 23 16 14 14 1 17 17 2 15 13
2023/2024201 12 15 8 10 12 22 14 28 7 34 18 21
2024/2025134 10 52 33 39 0 0 0 0 0 0 0 0
Totale 822